2 Likes
Interesting, thank you!
Quote
Extrapyramidal symptoms were significantly higher (MD: 0.39; 95% CI:0.19-0.60; p = 0.0002) in the sodium benzoate group in comparison to the control group; however, there was no significant difference in respect to other adverse events.
Maybe they will later come up with a better molecule.
1 Like